Oruka Therapeutics, Inc.

NASDAQ:ORKA

Biotechnology

Healthcare
$95.74 +0.65%

+$0.46 today

Market cap
$6.49B
Beta
-0.30
P/E (TTM)
-33.9
EPS (TTM)
-$2.11
52W Low $10.77High $91.00

Volume 0.52M

Average 1.55M

Balance Sheet

Inspect the capital base behind the business.

Assets

$488.62M

FY 2025 · Annual

+23.4% YoY

Liabilities

$16.69M

FY 2025 · Annual

+20.9% YoY

Equity

$471.93M

FY 2025 · Annual

+23.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents53.36M42.45M37.43M61.58M46.94M
Short-term Investments000314.07M290.11M
Net Receivables00000
Inventory00000
Other Current Assets1.06M254K161K1.22M6.81M
Total Current Assets54.42M42.7M37.59M376.87M343.86M
Property, Plant & Equipment (Net)485K368K257K1.04M2.12M
Goodwill00000
Intangible Assets00000
Long-term Investments00018.07M142.54M
Tax Assets00000
Other Non-current Assets18K18K12K43K103K
Total Non-current Assets503K386K269K19.15M144.76M
Total Assets54.92M43.09M37.86M396.02M488.62M
Account Payables1.12M334K03.46M4.16M
Short-term Debt100K103K76K213K619K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.36M522K461K7.33M5.33M
Total Current Liabilities3.5M1.13M637K13.04M15.37M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities383K280K204K755K1.31M
Total Liabilities3.88M1.41M841K13.8M16.69M
Common Stock14K14K14K37K49K
Retained Earnings(173.48M)(183.4M)(188.74M)(83.72M)(189.16M)
Accumulated OCI000(41K)546K
Other Stockholders Equity00000
Minority Interest00000
Total Equity51.04M41.67M37.02M382.22M471.93M
Total Debt483K383K280K968K1.93M
Net Debt(52.88M)(42.06M)(37.15M)(60.61M)(45M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$191.5M
Short-term Investments$728.8M
Other Current$21.2M
Total Current Assets$941.5M
PP&E (Net)$3.1M
Long-term Investments$286.3M
Other Non-current$128.0K
Total Non-current Assets$289.5M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $728.8M, about 59.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 2, 2026
8-KCurrent reportOct 26, 2026

How much cash does ORKA have?

Oruka Therapeutics, Inc. (ORKA) reported $46.94M in cash and equivalents in fiscal 2025.

How much debt does ORKA carry?

Oruka Therapeutics, Inc. (ORKA) reported $1.93M of total debt, with net debt of -$45.00M.